AML cells treated with rapamycin showed significant decreased expression of p-p70S6K, significant decreased in vimentin at higher dose (100nM) and slightly increased expression of N-cadherin (100nM) (Fig. 2A,C,D). This evidence concerns the gene RPS6KB1 and acute myeloid leukemia.